Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 7,137 | 20,968 | 41,867 | 23,028 | 135,082 |
| Cost of Goods | 620 | 6,174 | 7,266 | N/A | N/A |
| Gross Profit | 6,517 | 14,794 | 34,601 | 23,028 | 135,082 |
| Operating Expenses | 65,520 | 136,463 | 122,402 | 112,111 | 129,697 |
| Operating Income | -58,383 | -121,495 | -87,535 | -89,083 | 5,385 |
| Other Income | -12,882 | 2,982 | 2,061 | 642 | 2,334 |
| Pre-tax Income | -71,265 | -118,513 | -85,474 | -88,441 | 7,719 |
| Income Tax | -398 | N/A | N/A | N/A | -691 |
| Net Income Continuous | -70,867 | -118,513 | -85,474 | -88,441 | 8,410 |
| Net Income | $-70,867 | $-118,513 | $-85,474 | $-88,441 | $8,410 |
| EPS Basic Total Ops | -46.59 | -78.79 | -57.37 | -62.67 | 6.48 |
| EPS Basic Continuous Ops | -46.60 | -78.81 | -57.36 | -62.81 | 6.39 |
| EPS Diluted Total Ops | -46.59 | -78.79 | -57.37 | -62.67 | 6.48 |
| EPS Diluted Continuous Ops | -46.60 | -78.81 | -57.36 | -62.81 | 6.32 |
| EPS Diluted Before Non-Recurring Items | -38.16 | -78.88 | -57.27 | -62.67 | 6.48 |
| EBITDA(a) | $-57,968 | $-119,561 | $-85,601 | $-86,668 | $6,554 |